Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Flamel Technologies S.A. FLML

Healthcare Biotechnology
"Flamel Technologies SA is a specialty pharmaceutical company engaged in drug delivery and formulation development to create safer and more efficacious pharmaceutical products to address unmet medical needs and/or reduce overall healthcare costs."

Recent & Breaking News (NDAQ:FLML)

Flamel Technologies Announces Positive Results From First Clinical Trials With Trigger Lock(TM) Hydromorphone Abuse-Deterrent Product

Marketwired June 29, 2015

Flamel Technologies Appoints SVP of Quality and Regulatory Affairs and VP of Business and Corporate Development

Marketwired June 26, 2015

Flamel Technologies to Present at JMP Securities Life Sciences Conference

Marketwired June 16, 2015

Updated Time - Flamel Technologies to Present at Jefferies 2015 Healthcare Conference

Marketwired May 27, 2015

Flamel Technologies to Present at Jefferies 2015 Healthcare Conference

Marketwired May 22, 2015

Flamel Technologies Announces First Quarter Results of Fiscal Year 2015

Marketwired May 15, 2015

Flamel Technologies to Report First Quarter of Fiscal Year 2015 Results

Marketwired May 6, 2015

Flamel Technologies Announces Departure of Senior Vice President of Business and Corporate Development

Marketwired April 7, 2015

Flamel Technologies Announces Positive Results of a First-in-Man Clinical Trial With LiquiTime(R) Guaifenesin

Marketwired March 27, 2015

Flamel Technologies Announces Fourth Quarter and Full Year Results of Fiscal Year 2014

Marketwired March 19, 2015

Flamel Technologies to Report Fourth Quarter of Fiscal Year 2014 Results

Marketwired March 6, 2015

Flamel Technologies to Present at Two Upcoming Investor Conferences

Marketwired March 5, 2015

Flamel Technologies Announces Price Change for Bloxiverz

Marketwired January 15, 2015

Flamel Technologies Update to Shareholders on Neostigmine Methylsulfate

Marketwired January 14, 2015

Flamel Technologies Announces Positive Results of a Second Clinical Trial With Micropump(R) Sodium Oxybate

Marketwired December 19, 2014

Flamel Technologies Transfers Intangible Property to Irish-Based Subsidiary in Global Reorganization

Marketwired December 16, 2014

Flamel Technologies to Be Included in NASDAQ Biotech Index

Marketwired December 15, 2014

Flamel Technologies Closes Sale of Development and Manufacturing Facility in Pessac, France to Recipharm AB

Marketwired December 1, 2014

Flamel Technologies Sells Development and Manufacturing Facility in Pessac, France to Recipharm AB

Marketwired November 28, 2014

Flamel Technologies Announces Third Quarter Results of Fiscal Year 2014

Marketwired October 31, 2014